chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine associated immune thrombocytopenia; This literature-non-study case was reported in a literature article and describes the occurrence of IMMUNE THROMBOCYTOPENIA (Vaccine associated immune thrombocytopenia) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.   LITERATURE REFERENCE:     No Medical History information was reported.    On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNE THROMBOCYTOPENIA (Vaccine associated immune thrombocytopenia) (seriousness criterion medically significant). At the time of the report, IMMUNE THROMBOCYTOPENIA (Vaccine associated immune thrombocytopenia) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered IMMUNE THROMBOCYTOPENIA (Vaccine associated immune thrombocytopenia) to be related.    Treatment and concomitant medications were not reported.  Company comment: This literature non study case concerns a 83-year-old, male patient with no medical history information reported, who experienced the unexpected serious (medically significant) AESI of immune thrombocytopenia. The events occurred on an unknown date after the fourth dose of mRNA-1273. No further information about the events was available at the time of this report. The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to MODERNATX, INC.-MOD-2022-658144 (E2B Linked Report).; Sender's Comments: This literature non study case concerns an 83-year-old, male patient with no medical history information reported, who experienced the unexpected serious (medically significant) AESI of immune thrombocytopenia. The events occurred on an unknown date after the fourth dose of mRNA-1273. No further information about the events was available at the time of this report. The benefit-risk relationship of mRNA-1273 is not affected by this report. MODERNATX, INC.-MOD-2022-658144:66 YO Female
- Same day of vaccinations, leg swelling and red. Went to ER after Tylenol and cold pack did  not improve. "Local Reaction" per ER doctor. CRNP spoke with mother 11-5-07, redness and swelling, much better.
broke out with cold sores; This is a spontaneous report from a contactable consumer.   A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as 1st Dose, Single Dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that she had first dose (she confirmed it was Pfizer-BioNTech COVID-19 Vaccine) almost 3 weeks ago, when I probed for the date, she did not specify the date of first nor the second dose, only stated she is scheduled for second dose in the next few days. The patient broke out with cold sores. She just want to know if I should go get second dose and wanted to know if taking it could weaken the vaccine. Therapeutic measures were taken as a result of broke out and being using topical Abreva. The outcome for the events was Unknown.  No follow-up attempts are possible. Information about Lot/batch number cannot be obtained.
Rash starting on his back.  On 7/1/14 it has spread all over his trunk, arms, legs.  He is running a fever and fussy.
Received the shot 4 days ago immediately 40 mins later my face started tingly and it is day 4 now and its tingly on left side and numb like pins and needles; Received the shot 4 days ago immediately 40 mins later my face started tingly and it is day 4 now and it's tingly on left side and numb like pins and needles; numb like pins and needles; This is a spontaneous report from a contactable healthcare professional, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: PFIZERER0733) via an unspecified route of administration in the right arm on 29Mar2021 at 17:30 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other medication within two weeks of vaccination. The patient did not report any known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 29Mar2021 at 18:15 immediately 40 minutes after the vaccination, the patient face started tingly and it was day 4 and it was tingly on left side and numb like pins and needles. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Treatment was not received for the reported events. The clinical outcome of the events tingly, numb, like pins and needles were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Information has been received from a registered nurse concerning a 5 year old female patient who on 06/14/1999 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck).  In February 2004, the patient developed a mild case of breakout chickenpox.  Unspecified medical attention was sought, but treatment was not required.  Subsequently, the patient recovered.  A product quality complaint was not involved.  The patient also mentioned another patient who developed chickenpox post vaccination with varicella virus vaccine live.  Additional information is not expected.
General feeling of not feeling well. Fatigue. Started two days after shot, still going on a little.
Patient noticed that area near injection site had become red, warm and firm to the touch. Denies any other symptoms.
Client's Mother asked EMTs  to assess daughter as she was falling asleep on chair. Vitals at 1819: blood pressure 118/80, pulse 90, oxygen 99%. PHN joined shortly after. Upon arrival client sitting upright on chair, awake, alert and oriented x4. Mother stated not knowing if it was normal for client to feel fatigued shortly after vaccine. Per Mother client had already waited 15 mins and no reactions to first dose. Client currently on antibiotic treatment for throat infection. Mother stated client has been up since 0800, went to school and has been out all day. Client stated she just feels tired. Client denied shortness of breath, chest pain, headache, dizziness, or blurry vision. Client awake and alert x4 during time PHN was with client. Mother advised to monitor client at home, ER precautions also given. Last vitals at 1825: blood pressure 116/82, pulse 88, oxygen 99%. Client left facility with steady gait at 1830, Mother was driving client home
Patient states rash - splotchy, then erythema around site. Rash lasted 1 week.
Within 4 hours of receiving the J&J vaccine I was experiencing tinnitus,  nasal congestion,  pain in my right ear and sinuses, and a "full" feeling in my right ear. Went to a doctor after about 10 days and was given a 10 days  of prednisone and antibiotic for my symptoms and estuation tube dysfunction,    After about  a month, I was not having the sinus pain and ear pain as much.  Still get a "full" feeling and congestion  regularly.   But the tinnitus has not stopped from it starting.!
Patient received COVID vaccine @ 17:15 patient stated she was dizzy as soon as she received the vaccine. EMS assessed patient and took her vitals. Vitals are stabled and patient felt better after a few mins. She then requested to leave.
shot at 1:40pm, itching arm at 1:50pm, 25mg Benadryl at 1:55pm, 25mg Benadryl at 2:00pm, red and itching behind arm left and right, red and hives on chest, petechiae small spots on belly area  and back, 2:20pm redness and itching and hives and petechiae not improved.
Vials of Pfizer COVID vaccine were stored in the refrigerator with a use-date expiration on 10/19 at 1:30pm. On 10/19, approximately 2 hours after this, the patient was given their first dose of COVID vaccine with this vial.  No harm detected.
Patient received vaccine and left vaccination area to wait the 15 mins post vaccination. About 10 mins after vaccine administration, patient's father reported that she had lost consciousness while sitting. Patient was coming to as nurse approached. Patient aroused and was able to answer questions appropriately in about 2 mins after the incident.
patient received an expired dose of Infanrix/ expired on May31st, 2021; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 4-year-old patient who received DTPa (Infanrix) (batch number unknown, expiry date 31st May 2021) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 2nd June 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 2nd June 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The nurse reported that the patient received an expired dose of Infanrix, which led to expired vaccine used. The HCP declined provide patient's information The reporter did not consent to follow up.
My tongue is tingly on side and underneath the sides (very similar to eating too much pineapple) and effecting taste buds on sides of tongue.
Red Spot on Cheek; got the injection on her arm, it is red around the injection site and then went down her arm and back up; broke out in little red bumps on her chest and her arms, and it was the same kind of redness where she had the shot injection; also on her legs/rash on chest spreading down arm; This is a spontaneous report from a contactable consumer (patient). A 76-years-old female patient received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EP6955, Expiration date and NDC number was unknown), via an unspecified route of administration, administered in right arm on 28Mar2021 at 11:15 hours as 2nd dose, single dose (at the age of 76-years-old) for covid-19 immunisation. Patient's had no medical history (including any illness at time of vaccination) and relevant family medical history. Concomitant medication(s) included vitamins (occasionally takes vitamins) taken for an unspecified indication, start and stop date were not reported. Patient received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EN6205, Expiration date and NDC number was unknown), via an unspecified route of administration, administered in right arm on 07Mar2021 as 1st dose, single dose (at the age of 76-years-old) for covid-19 immunisation. Patient had no prior vaccinations (within 4 weeks). Patient stated that initially after first dose, there was no redness at injection site. On 05Apr2021, patient now indicates a big red circle/red around the injection site, patient had it since it just popped up 2 weeks after the shot. Patient stated it was red around the injection site and then went down her arm and back up and it was worsened and then she broke out in little red bumps on her chest and spreading down arm/rash on chest spreading down arm, and it was the same kind of redness where she had the shot injection. Patient stated she also had a few on her legs. Patient stated she was not sure if it was an allergic reaction or how to treat it. Patient stated the redness was on her arm down to her elbow, it was pink and red and warm and then it went away, and now it was just red at the injection site. Patient was trying sensitive soap bout expensive sensitive soap to try and dry them up as treatment as it was a two month delay to see dermatologist. Patient also reports on cheek starting last week. On 26May2021, patient had red spot on cheeks. The outcome for broke out in little red bumps on her chest and her arms, and it was the same kind of redness where she had the shot injection; also on her legs/rash on chest spreading down arm in 2021 was recovered and for rest of the events was not recovered.
Patient's mom showed RN rash to both upper thighs that had appeard the day after immunizations were given to this area.  Rash was seen by RN on 4th day after immunizations were given.  both upper thighs had small raised red bumps.  Alcohol wipes had been used to cleanse thighs before immunizations had been given.  Rash resolved with treatment within a week.
Developed small non tender nodes rt post auricular, left anterior cervical and left occipital 2 days ago.
She got a letter stating that she tested positive for HIV; This is a spontaneous report from the Pfizer sponsored program,  via a contactable consumer (patient). A 56-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient previously received the first dose of BNT162B2 for COVID-19 immunization. The patient received both doses of Pfizer's COVID vaccine and 3 weeks later, she donated blood to red cross. She got a letter stating that she tested positive for HIV and wanted to know if the vaccine would cause a false positive test for HIV or if this had ever been reported. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Chills,fever,fatigue for 4 days and swollen sore arm from the injection for 4 days.The symptoms were the same symptoms as when I had Covid -19 in December 2020.
Pt complained of swelling to the inside of her mouth and a dry scratchy throat about 15 minutes after receiving the vaccine while in the observation area. Pt brought to private area for monitoring. VS stable: BP132/85 HR 74 O2 sat 98% on room air. No visible sign of swelling to the face or lips. Continued monitoring pt for 30 min. Symptoms decreased and pt felt comfortable going home with her son. Educated pt to seek emergency care if symptoms worsen, develops SOB or feeling of throat closing. Pt verbalized understanding and was sent home with son with instructions to inform primary care doctor.
Had the booster dose and then got COVID again; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (Had the booster dose and then got COVID again) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Had the booster dose and then got COVID again). At the time of the report, COVID-19 (Had the booster dose and then got COVID again) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details were reported.  No treatment medication details were reported.  Company comment: This is a spontaneous case concerning a male patient of an unknown age with no medical history reported;  who experienced unexpected event of COVID-19 (AESI). The event occurred on an unknown date after the administration of mRNA-1273 vaccine. The reporter of the case mentioned that he knows 1 person that got 2 doses of the Moderna COVID-19 vaccine and then got COVID. Then had the booster dose and then got COVID again. Clinical course and treatment details were not provided. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.    This case was linked to MOD-2021-414521 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a male patient of an unknown age with no medical history reported;  who experienced unexpected event of COVID-19 (AESI). The event occurred on an unknown date after the administration of mRNA-1273 vaccine. The reporter of the case mentioned that he knows 1 person that got 2 doses of the Moderna COVID-19 vaccine and then got COVID. Then had the booster dose and then got COVID again. Clinical course and treatment details were not provided. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Presented with SOB; + covid ED: Admit OBS with Pulmonary Edema and Covid PNA; + Covid in August; then - test 9/19; then + 9/24 and CXR with PNA: It states "represents probably a burnt out case   Covid 19"; tx with  Vit C, Rocephin, steroids, zinc; O2 @ 40% Bipap with admit; Down to Room Air at D/C
By having a primary vaccination and a Pfizer Booster, I got a case of COVID-19 on July 1, 2022 and my symptoms were more than mild. I had joint pain, fever, headache, brain fog, exhaustion, coughing.  I am a lot better but tested positive today, July 6, 2022.
Severe flu-like symptoms: shivering, cold sweats, whole body pain, severe pain at injection sight and left arm. Symptoms began approximately 6 hours after injection. My reaction to this second vaccine was much more severe than my reaction to the 1st does, which was more like common cold symptoms. I have literally been confined to bed for 24 hours.   Further note: I have received many vaccinations at this location and vaccine was administered correctly.
Swelling, redness, fever (welps). Tx: TYLENOL, MOTRIN for pain; Prednisolone 15/5 1 tsp. BID x 6 days for swelling.
had an allergic reaction from the 1st shot; This is a spontaneous report from a Pfizer sponsored program. A contactable female of an unspecified age consumer reported for herself that she received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number, Expiry Date: not reported), via an unspecified route of administration on 08Mar2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced had an allergic reaction from the 1st shot on 08Mar2021. She wanted to know if it was safe to take the 2nd shot. The outcome of event was unknown.  The lot number for the vaccine, [bnt162b2], was not provided and will be requested during follow up.
Severe headache pain on the first to third day  and the fourth day back of my head the left side pain dizziness, nauseou, chill and stomach pain
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date).    No concomitant information was reported. BUD reported as 17Feb2022. No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non significant FU
Miscarriage at 6 weeks gestation; heartbeat had been confirmed previously and pregnancy confirmated as viable and healthy
Client reported dizziness and requested an ambulance. BP taken and client continued to report dizziness. Client moved to lay down on the floor and elevated feet. Client then started to report numbness in his tongue and the room "spinning." EMSA called. O2 via non-rebreather given. BP continued to be monitored (130/82 at 1023, 142/78 at 1027, 130/81 at 1037). Client reported symptoms improved- tongue no longer numb. EMSA arrived at 1040 and client transported to ambulance and taken to hospital for further evaluation.
STOMACH DISCOMFORT; WEAKNESS; LIGHTHEADED; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 30-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 01-MAY-2021, the subject experienced lightheaded. On 01-MAY-2021, the subject experienced weakness. On 03-MAY-2021, the subject experienced stomach discomfort. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from lightheaded, and had not recovered from weakness, and stomach discomfort. This report was non-serious.
Hot near injection site; Swelling near injection site; This case was reported by a consumer via interactive digital media  and described the occurrence of injection site warmth in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine, the patient experienced injection site warmth and injection site swelling. On an unknown date, the outcome of the injection site warmth and injection site swelling were unknown.   It was unknown if the reporter considered the injection site warmth and injection site swelling to be related to Shingles vaccine.  Additional case details were reported as follows: The case was reported by the patient. Age at vaccination was not reported. The patient received the 2-shot last year.  After the 1st dose of Shingles vaccine, it was just hot swelling near the injection site. For tolerance in 2nd dose refer case US2021AMR178359. No contact details were reported.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR178359:Same reporter.
Vaccine recipient woke up 2/17/21 at approximately 7 AM with itchy skin and small hives. Around 8 AM she had difficulty breathing, and when she went in to be seen at her clinic she had difficulty swallowing. At this time, an ambulance was called and she was transported to the ER.